Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure Sells 22,700 Shares

Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure sold 22,700 shares of the firm’s stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $4.15, for a total transaction of $94,205.00. Following the completion of the sale, the chief executive officer now owns 1,030,209 shares of the company’s stock, valued at $4,275,367.35. This trade represents a 2.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Inotiv Price Performance

Shares of NOTV stock opened at $4.18 on Thursday. Inotiv, Inc. has a twelve month low of $1.23 and a twelve month high of $11.42. The stock has a market cap of $108.72 million, a price-to-earnings ratio of -1.00 and a beta of 3.58. The company has a quick ratio of 1.22, a current ratio of 1.37 and a debt-to-equity ratio of 2.29. The business’s fifty day moving average is $4.43 and its 200 day moving average is $2.80.

Inotiv (NASDAQ:NOTV) last posted its quarterly earnings data on Wednesday, February 5th. The company reported ($0.42) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.10). Inotiv had a negative net margin of 22.10% and a negative return on equity of 15.86%. Research analysts expect that Inotiv, Inc. will post -0.75 EPS for the current fiscal year.

Hedge Funds Weigh In On Inotiv

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Renaissance Technologies LLC boosted its holdings in Inotiv by 29.9% in the second quarter. Renaissance Technologies LLC now owns 164,164 shares of the company’s stock worth $273,000 after purchasing an additional 37,800 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Inotiv by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock valued at $427,000 after buying an additional 18,039 shares during the period. Thurston Springer Miller Herd & Titak Inc. boosted its stake in shares of Inotiv by 612.5% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock worth $527,000 after buying an additional 109,397 shares during the last quarter. KPP Advisory Services LLC increased its position in Inotiv by 15.8% during the fourth quarter. KPP Advisory Services LLC now owns 275,267 shares of the company’s stock valued at $1,140,000 after acquiring an additional 37,549 shares during the last quarter. Finally, Vantage Point Financial LLC bought a new position in Inotiv in the fourth quarter valued at about $1,393,000. Institutional investors own 18.17% of the company’s stock.

Inotiv Company Profile

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.